Form N-VP/A Variable Annuity-2 Serie
Supplement dated October 21, 2025, to the Annual Notice dated
May 1, 2025, for Great-West Smart Track® Variable
Annuity, Great-West Smart Track® II Variable Annuity
and Great-West Smart Track® II - 5 Year Variable
Annuity
contracts issued by Empower Annuity Insurance Company of America
Variable Annuity-2 Series Account
Supplement dated October 21, 2025, to the Annual Notice dated
May 1, 2025, for Great-West Smart Track® Variable
Annuity and Great-West Smart Track® II - 5 Year
Variable Annuity
contracts
issued by Empower Life & Annuity Insurance Company of New York
Variable Annuity-2 Series Account of New York
This Supplement amends certain information in your variable annuity contract Annual Notice. Please read this Supplement carefully and keep it with your Annual Notice for future reference.
On or about November 1, 2025, a Portfolio available under your Contract will change its name as follows:
| CURRENT PORTFOLIO NAME | NEW PORTFOLIO NAME |
| LVIP Macquarie U.S. REIT Fund | LVIP Nomura U.S. REIT Fund |
After November 1, 2025, all references to the Portfolio in your Annual Notice will use the new Portfolio name.
Additionally, effective on or about November 1, 2025, Delaware Investments Fund Advisers, a Sub-Adviser to the Portfolio, will be changing its name to Nomura Investments Fund Advisers and any reference in the APPENDIX: INVESTMENT OPTIONS AVAILABLE UNDER THE CONTRACT section of the Annual Notice is hereby replaced with the new name.
If you have any questions regarding this Supplement, please contact your investment professional or us by calling toll free at 1-877-723-8723. You may also obtain fund prospectuses online at www.protective.com/productprospectus by selecting your Contract then “Investment Options”.
Please keep this Supplement for future reference.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sustainable Real Estate Forum Convenes Senior Industry Leaders at London Climate Action Week 2026
- VALLOUREC CONFIRMS ITS INTENTION TO RETURN CLOSE TO €650 MILLION TO SHAREHOLDERS IN 2026 FOLLOWING THE COMPLETION OF ITS SHARE BUYBACK PROGRAM AND THE FULL EXERCISE OF THE WARRANTS
- Addex Announces Publication of Research Highlighting Therapeutic Potential of mGlu7 Modulation in Regulating Sleep and Wakefulness
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share